Abstract
Comprehensive care for hemophilia patients has clearly demonstrated that it is cost effective and offers the patient a better, more active life. However, the cost of underwriting the core personnel has not been adequately addressed or resolved.Alternatives are presented which include a) federal or state support, b) third party reimbursement mechanisms, c) liaisons with blood programs and, d) cost overrides on product.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
